Yanus et al.8identified 6 MAP patients (6.7%) in a cohort of 90 KRAS‐G12C tumors, and Georgeson et al.2detected 16 (11%) out of 143 KRAS‐G12C/CRC cases as MAP. This evidence concerns the gene KRAS and familial adenomatous polyposis 2.